EUVIMEDEUVIMED entdecken
Open Access

Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors

Fabio R Faucz iD, Anelia D Horvath, Guillaume Assié, Madson Q Almeida, Eva Szarek, Sosipatros Boikos, Anna Angelousi, Isaac Levy, Andrea G Maria, Ajay Chitnis, Cristina R Antonescu, Rainer Claus und 4 weitere

Endocrine-Related Cancer · 2023

DOI: 10.1530/erc-23-0067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Fabio R Faucz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and…. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms, believed to originate from the interstitial cells of Cajal (ICC), often caused by overexpression of tyrosine kinase receptors (TKR) KIT or PDGFRA. Here, we present evidence that the embryonic stem cell factor FOXD3 , first identified as ‘Genesis’ and involved in both gastrointestinal and neural crest cell development, is implicated in GIST pathogenesis; its involvement is investigated both in vitro and in zebrafish and a mouse model of FOXD3 deficiency. Samples from a total of 58 patients with wild-type GISTs were used for molecular analyses, including Sanger sequencing, comparative genomic hybridization, and methylation analysis. Immunohistochemistry and western blot evaluation were used to assess FOXD3 expression. Additionally, we conducted in vitro functional studies in tissue samples and in transfected cells to confirm the pathogenicity of the identified genetic variants. Germline partially inactivating FOXD3 sequence variants (p.R54H and p.Ala88_Gly91del) were found in patients with isolated GISTs. Chromosome 1p loss was the most frequent chromosomal abnormality identified in tumors. In vitro experiments demonstrate the impairment of FOXD3 in the presence of those variants. Animal studies showed disruption of the GI neural network and changes in the number and distribution in the ICC. FOXD3 suppresses KIT expression in human cells; its inactivation led to an increase in ICC in zebrafish, as well as mice, providing evidence for a functional link between FOXD3 defects and KIT overexpression leading to GIST formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsGastrointestinal NeoplasmsHumansAnimalsMiceZebrafishStem Cell FactorComparative Genomic HybridizationProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaTranscription FactorsEmbryonic Stem CellsMutationForkhead Transcription Factors

Stichwörter der Autor:innen

Carney triadCarney–Stratakis syndromeFOXD3GISTinterstitial cells of Cajal

Substanzen

Stem Cell FactorProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaTranscription FactorsFOXD3 protein, humanForkhead Transcription Factors

Autor:innen und Institutionen

  • Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland,…
  • Department of Pharmacology and Physiology, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, United States of America.
  • Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France.
  • Endocrine Department, Center for Rare Adrenal Diseases, AP-HP, Hôpital Cochin, Paris, France.
  • Adrenal Unit, Laboratory of Molecular and Cellular Endocrinology LIM/25, Division of Endocrinology and Metabolism, University of Sao Paulo Medical School, São Paulo, Brasil.
  • Laboratory of Molecular Genetics, Section on Neural Developmental Dynamics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United Stat…

ORCID-Profile: Fabio R Faucz, Christoph Plass, Charis Eng, Constantine A Stratakis

Förderung

  • NCI NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Faucz, F. R., Horvath, A. D., Assié, G., Almeida, M. Q., Szarek, E., Boikos, S., Angelousi, A., Levy, I., Maria, A. G., Chitnis, A., Antonescu, C. R., Claus, R., Bertherat, J., Plass, C., Eng, C., & Stratakis, C. A. (2023). Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0067

Vancouver

Faucz FR, Horvath AD, Assié G, Almeida MQ, Szarek E, Boikos S, et al. Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors. Endocrine-Related Cancer. 2023. doi:10.1530/erc-23-0067

BibTeX
@article{Faucz2023,
  author = {Faucz, Fabio R and Horvath, Anelia D and Assié, Guillaume and Almeida, Madson Q and Szarek, Eva and Boikos, Sosipatros and Angelousi, Anna and Levy, Isaac and Maria, Andrea G and Chitnis, Ajay and Antonescu, Cristina R and Claus, Rainer and Bertherat, Jérôme and Plass, Christoph and Eng, Charis and Stratakis, Constantine A},
  title = {Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  doi = {10.1530/erc-23-0067}
}
Kostenlos starten →